Wedbush Securities’s Antares Pharma, Inc. ATRS Stock Holding History

Wedbush Securities’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-16,485	Closed	-$68K	–	1194
2022 Q1	$68K	Hold	16,485	–	–	﹤0.01%	1070
2021 Q4	$59K	Hold	16,485	–	–	﹤0.01%	1152
2021 Q3	$60K	Hold	16,485	–	–	﹤0.01%	1151
2021 Q2	$72K	Buy	+16,485	New	+$67.2K	﹤0.01%	1141

Other funds holding ATRS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Wedbush Securities's ATRS Position: Q2 2022 in Review

Wedbush Securities sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 16,485 shares — an estimated $68K sold.

Wedbush Securities first reported a position in ATRS in Q2 2021 and held it in 4 quarters. The position peaked at $72K in Q2 2021. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

Wedbush Securities reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
Wedbush Securities sold 16,485 Antares Pharma, Inc. shares in Q2 2022, an estimated $68K.
Wedbush Securities first reported a position in Antares Pharma, Inc. in Q2 2021 and held it in 4 quarters.
Wedbush Securities's Antares Pharma, Inc. position peaked at $72K in Q2 2021.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Wedbush Securities's 13F filing for Q2 2022, filed 21 Jul 2022.